Green Sands Equity

Paradromics, Inc. is focused on developing advanced brain-machine interfaces aimed at enhancing communication between the brain and external devices, particularly for individuals with neurodegenerative diseases. The company specializes in creating implantable systems that facilitate neural data decoding, allowing complex brain signals to be translated into data streams suitable for various neural prostheses. Paradromics is dedicated to providing high data-rate brain-computer interface technology that supports bidirectional data transmission, enabling patients to regain functionality lost due to neurological conditions. Founded in 2015, the company is headquartered in Austin, Texas.

PASQAL is developing a full-stack quantum computer that will be used to simulate complex phenomena for scientific discovery and to address general problems such as optimization, drug discovery, and machine learning. The company's quantum processing units are made up of hundreds of atomic qubits in 2D and 3D arrays, and their programming environment, to address our customers' needs in quantum computing and simulation.

ArsenalBio is a programmable cell therapy company established in 2019, focused on developing effective and accessible immune cell therapies, primarily targeting cancer treatment. The company utilizes advanced technologies, including CRISPR-based genome engineering, synthetic biology, and machine learning, to create a new paradigm for discovering and developing immune cell therapies. ArsenalBio's innovative approach aims to enhance the efficacy and safety of T-cell therapies while reducing costs for providers and broadening patient access. By employing a full-stack research and development engine, ArsenalBio generates multifunctional T-cell medicines through the precise insertion of large synthetic DNA sequences, enabling clinicians to utilize next-generation autologous T-cell therapies to combat cancer more effectively.

Stepful helps those without college degrees train for and find entry-level healthcare jobs.

Good Chemistry Company is making the world healthier, cleaner, and more sustainable by accelerating material design.Their proprietary QEMIST Cloud, a cloud-based computational chemistry platform, provides the building blocks for computational chemistry developers to build chemical simulation applications and workflows, using emerging algorithms in quantum chemistry, machine learning, and quantum computing.

Colossal Biosciences is a bioscience and genetic engineering company dedicated to the restoration of extinct species and the protection of endangered ones. By leveraging advanced gene editing technologies such as CRISPR, the company focuses on reviving species like the woolly mammoth and enhancing ecosystems. Colossal aims to address pressing issues related to extinction and biodiversity loss through innovative solutions that support the repopulation of critical ecosystems. Their work seeks not only to restore the natural balance of the environment but also to consider the future economic and biological needs of humanity.

Devoted Health is a healthcare company focused on enhancing the health and well-being of older Americans by treating each individual with care and compassion. The company offers an integrated healthcare solution that includes Medicare Advantage plans, access to local providers, and the option for virtual and in-home care through Devoted Medical. Their approach includes personalized medical plans and dedicated guides who work closely with physicians to streamline care and minimize unnecessary procedures. By leveraging advanced technology and a robust network of healthcare professionals, Devoted Health aims to provide high-quality, tailored healthcare services to its members.

USA Rare Earth LLC is engaged in the exploration and processing of critical minerals, specializing in rare earth elements, lithium, high-tech metals, uranium, and beryllium. Founded in 2019 and based in New York, the company operates the Round Top Heavy Rare Earth, Lithium and Critical Minerals Project, in which it holds an 80% interest. The Round Top project is notable for its diverse array of heavy rare earth elements and is anticipated to be among the lowest-cost producers of rare earths and lithium globally. By supplying these essential materials, USA Rare Earth aims to support industries such as defense and consumer electronics, contributing to advancements in energy, mobility, and national security.

Commure, Inc. is a technology company that develops an open platform aimed at healthcare software developers, enabling the creation and deployment of advanced healthcare applications. The platform is built on the open HL7 FHIR standard and offers various features, including an FHIR API server, security framework, event service bus, EHR integration, and a flexible data store. Commure's solutions facilitate the unification of disparate datasets, providing meaningful insights and enhancing performance through intuitive applications. The company collaborates with health systems, digital innovators, and payors to foster a vibrant healthcare ecosystem, ultimately empowering clinicians and staff to improve patient care. Established in 2017, Commure is headquartered in San Francisco, California, with additional offices in Boston, Montreal, and Bogota.

AST SpaceMobile is a satellite designer and manufacturer headquartered in Midland, Texas, focused on creating the first global broadband cellular network in space. The company aims to connect users directly through standard, unmodified mobile devices, leveraging its extensive intellectual property and patent portfolio. Established in 2017, AST SpaceMobile seeks to address the connectivity gaps experienced by the five billion mobile subscribers worldwide and to provide broadband access to the billions who remain unconnected. Its spaceMobile service is designed to deliver cost-effective, high-speed cellular broadband to users outside of terrestrial cellular coverage, utilizing existing mobile technology.

ReViral is a developer of antiviral drugs designed to help patients and enlarge the antiviral market by developing novel first-in-class compounds. The company's antiviral drugs is a fusion inhibitor of RSV which is a highly potent, novel small molecule and is being developed to treat RSV in patients with severe disease including neonates, enabling patients to be treated who are infected with respiratory syncytial virus (RSV) by developing novel compounds.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders that involve neuronal imbalance. The company is advancing several lead product candidates, including PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator currently in Phase IIa trials for major depressive disorder and perimenopausal depression, and PRAX-944, a selective small molecule inhibitor of T-type calcium channels in Phase IIa trials for essential tremor. Additionally, Praxis is developing PRAX-562, a persistent sodium current blocker in Phase I trials for severe pediatric epilepsy and adult cephalgia, as well as PRAX-222, an antisense oligonucleotide targeting SCN2A epilepsy. The company also has a program for treating KCNT1 gain-of-function epilepsy. Established in 2015 and based in Cambridge, Massachusetts, Praxis collaborates with other organizations through various agreements to enhance its research and development efforts.

Encoded Therapeutics, Inc. is a biotechnology company that specializes in precision gene therapies aimed at treating a wide array of severe genetic disorders. Utilizing a unique platform, Encoded identifies sequences within the human genome that regulate gene expression through advanced screening and computational techniques. The company's therapy pipeline targets both genetic and acquired disorders across various disease pathways, including neurocircuitry, liver and metabolic disorders, neurodegeneration, and cardiovascular diseases. Founded in 2014 and based in South San Francisco, California, Encoded Therapeutics is focused on developing innovative solutions that enable medical practitioners to improve patient outcomes and enhance quality of life.

1QBit is a quantum computing software company that addresses complex computational challenges by reformulating problems to utilize the capabilities of quantum computing. The company develops software that combines machine intelligence and optimization science on a hardware-agnostic platform, allowing for innovative solutions across various applications. This approach enables clients and hardware providers to enhance their applications by leveraging advancements in both classical and quantum computing technologies.

Lyft is a transportation company that operates a mobile application designed to connect drivers with passengers seeking rides. Founded in 2013, it has become the second-largest ride-sharing service provider in the United States and Canada. The Lyft app allows users to request various types of rides, including private, shared, and luxury options, while also facilitating payment. In addition to ride-sharing, Lyft has expanded its services to include bike and scooter-sharing, promoting multimodal transportation solutions. The company primarily focuses on serving college, university, and corporate communities, and it enables riders to schedule rides up to seven days in advance.